Two former sales representatives for Insys Therapeutics pled guilty this week to breaking anti-kickback laws. The company makes Subsys, which contains fentanyl, a dangerous synthetic opioid.
Here & Now‘s Meghna Chakrabarti speaks with Linette Lopez (@lopezlinette) of Business Insider about why the company is in trouble, what legal issues other businesses could soon face, and how a crackdown could impact the opioid crisis in this country.
Copyright 2021 NPR. To see more, visit https://www.npr.org.